Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Goodwill & Intangibles (2016 - 2025)

Historic Goodwill & Intangibles for Collegium Pharmaceutical (COLL) over the last 10 years, with Q3 2025 value amounting to $870.9 million.

  • Collegium Pharmaceutical's Goodwill & Intangibles fell 2030.74% to $870.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $870.9 million, marking a year-over-year decrease of 2030.74%. This contributed to the annual value of $1.1 billion for FY2024, which is 8966.91% up from last year.
  • Collegium Pharmaceutical's Goodwill & Intangibles amounted to $870.9 million in Q3 2025, which was down 2030.74% from $928.4 million recorded in Q2 2025.
  • Over the past 5 years, Collegium Pharmaceutical's Goodwill & Intangibles peaked at $1.1 billion during Q1 2022, and registered a low of $268.7 million during Q4 2021.
  • For the 5-year period, Collegium Pharmaceutical's Goodwill & Intangibles averaged around $784.1 million, with its median value being $928.4 million (2025).
  • In the last 5 years, Collegium Pharmaceutical's Goodwill & Intangibles skyrocketed by 28045.38% in 2022 and then crashed by 5515.94% in 2024.
  • Collegium Pharmaceutical's Goodwill & Intangibles (Quarter) stood at $268.7 million in 2021, then surged by 160.92% to $701.2 million in 2022, then decreased by 20.77% to $555.6 million in 2023, then surged by 89.67% to $1.1 billion in 2024, then dropped by 17.35% to $870.9 million in 2025.
  • Its last three reported values are $870.9 million in Q3 2025, $928.4 million for Q2 2025, and $986.7 million during Q1 2025.